03/05/2024 6:54 PM | Editas Medicine (Issuer) Mei Baisong (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Editas Medicine (Issuer) O'Neill Gilmore Neil (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:03 PM | Burkly Linda (Reporting) Editas Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:06 PM | Editas Medicine (Issuer) Lucera Erick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 4:13 PM | Editas Medicine (Filer)
| Form S-3ASR | |
02/28/2024 3:39 PM | Editas Medicine (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2024 6:06 AM | Editas Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
02/14/2024 7:40 AM | Deep Track Capital, LP (Filed by) Editas Medicine (Subject)
| Form SC 13G/A | |
01/24/2024 1:27 PM | BlackRock Inc. (Filed by) Editas Medicine (Subject)
| Form SC 13G/A | |
01/10/2024 8:09 AM | Editas Medicine (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/13/2023 8:02 AM | Editas Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2023 3:23 PM | Editas Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/07/2023 3:30 PM | Eaton Bruce (Reporting) Editas Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 3:10 PM | Editas Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/16/2023 3:30 PM | Eaton Bruce (Reporting) Editas Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 6:06 AM | Editas Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 3:59 PM | Eaton Bruce (Reporting) Editas Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 3:30 PM | Eaton Bruce (Reporting) Editas Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/02/2023 6:16 AM | Editas Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/21/2023 3:30 PM | Editas Medicine (Issuer) Mei Baisong (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:30 PM | Editas Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/15/2023 3:22 PM | Editas Medicine (Filer)
| Form 424B5 | |
06/14/2023 4:20 PM | Editas Medicine (Filer)
| Form 424B5 | |
06/09/2023 5:01 AM | Editas Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2023 3:30 PM | Eaton Bruce (Reporting) Editas Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 3:30 PM | Editas Medicine (Issuer) O'Neill Gilmore Neil (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2023 4:18 PM | Editas Medicine (Issuer) Lucera Erick (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/18/2023 4:20 PM | Editas Medicine (Issuer) Lucera Erick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2023 5:41 PM | Editas Medicine (Subject) ROBERTSON MICHELLE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2023 3:16 PM | Editas Medicine (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/05/2023 6:16 AM | Editas Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/13/2023 4:09 PM | Editas Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/13/2023 3:52 PM | Editas Medicine (Issuer) Levy Elliott M. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 3:53 PM | Editas Medicine (Issuer) Levy Elliott M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |